Cargando…
Plasmodium falciparum genetic factors rather than host factors are likely to drive resistance to ACT in Ghana
BACKGROUND: Artemisinin-based combination therapy (ACT) partner drugs, currently used in Ghana are lumefantrine, amodiaquine and piperaquine. Plasmodium falciparum isolates with reduced susceptibility to these partner drugs may affect treatment outcome. Mutations in pfmdr1 gene is linked to reduced...
Autores principales: | Hodoameda, Peter, Duah-Quashie, Nancy Odurowah, Hagan, Charles Oheneba, Matrevi, Sena, Abuaku, Benjamin, Koram, Kwadwo, Quashie, Neils Ben |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7362516/ https://www.ncbi.nlm.nih.gov/pubmed/32669113 http://dx.doi.org/10.1186/s12936-020-03320-7 |
Ejemplares similares
-
Genetic diversity of Plasmodium falciparum isolates from uncomplicated malaria cases in Ghana over a decade
por: Duah, Nancy O., et al.
Publicado: (2016) -
Novel pfk13 polymorphisms in Plasmodium falciparum population in Ghana
por: Matrevi, Sena Adzoa, et al.
Publicado: (2022) -
Prevalence of Plasmodium falciparum delayed clearance associated polymorphisms in adaptor protein complex 2 mu subunit (pfap2mu) and ubiquitin specific protease 1 (pfubp1) genes in Ghanaian isolates
por: Adams, Tryphena, et al.
Publicado: (2018) -
Therapeutic efficacy of dihydroartemisinin-piperaquine combination for the treatment of uncomplicated malaria in Ghana
por: Abuaku, Benjamin, et al.
Publicado: (2023) -
Therapeutic efficacy of artesunate–amodiaquine and artemether–lumefantrine combinations for uncomplicated malaria in 10 sentinel sites across Ghana: 2015–2017
por: Abuaku, Benjamin, et al.
Publicado: (2019)